Financial Performance - Endava's revenue for the three months ended September 30, 2025 (Q1 FY25) was £195.1 million, while for the three months ended September 30, 2026 (Q1 FY26) it was £178.2 million, representing a year-over-year decrease of 8.6%[88, 90] - The adjusted profit before tax for Q1 FY25 was £19.232 million, and for Q1 FY26 it was £9.852 million[94] - Adjusted free cash flow for Q1 FY25 was £3.549 million, and for Q1 FY26 it was £9.209 million[116] - The adjusted profit before tax as a percentage of revenue was 9.9% for Q1 FY25 and 5.5% for Q1 FY26[94] Client Relationships - The number of clients with revenue greater than £1 million was 147 in Q1 FY25 and 133 in Q1 FY26[97] - The average spend for top 10 clients was £7.080 million in Q1 FY25 and £6.380 million in Q1 FY26[103] - The average spend for remaining clients was £289,000 in Q1 FY25 and £278,000 in Q1 FY26[105] - Revenue from the top 10 clients accounted for 36% of total revenue in both Q1 FY25 and Q1 FY26[100] Geographical and Vertical Revenue - In Q1 FY26, Europe accounted for 28% of revenue, North America 25%, and the UK 42%[110] - By industry vertical in Q1 FY26, Payments represented 17% of revenue, Banking & Capital Markets 22%, Insurance 9%, Technology, Media & Telecom 17%, Mobility 9%, Healthcare 12%, and Other 14%[110] Employees - As of September 30, 2025, Endava had 11,636 global employees, a 1.6% decrease from Q1 FY25[62]

Corporate Presentation November 2025 Safe Harbor This presentation contains "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Harrow, Inc. (the "Co ...

Financial Performance - The company's net investment income (NII) per share was $0.45, resulting in an annualized NII yield on book value of 10.3%[15] - Net income per share was $0.29, equating to an annualized return on book value of 6.6%[15] - The net asset value per share as of September 30, 2025, was $17.40, a decrease compared to $17.56 as of June 30, 2025[15] Portfolio Composition and Activity - The total investment portfolio at fair value was $2,534.1 million, primarily consisting of senior secured, floating-rate loans[15] - Gross investment fundings were $340.1 million, while net investment fundings amounted to $44.0 million[15] - The portfolio is highly diversified across 195 portfolio companies operating in 31 different industries[15] - First lien investments constitute 64% of the invested portfolio at fair value[24] - Investments on non-accrual represented 1.5% of the total investment portfolio at amortized cost and 0.7% at fair value as of September 30, 2025[15,39] Liquidity and Funding - The company reported strong liquidity totaling $570 million, including $457 million of undrawn capacity on a revolving credit facility[15] - Unsecured debt represents 63% of the total debt outstanding at quarter-end[15,55] Portfolio Yield and Debt - The weighted average yield at amortized cost on the investment portfolio was 11.1%[15] - Ending net debt-to-equity was 1.23x, compared to 1.20x as of June 30, 2025[15]

Overall Performance - Sea Limited experienced strong growth momentum in Q3 2025, with GAAP revenue reaching $6 billion[19] - The company's adjusted EBITDA increased to $874.3 million[16] - Sea Limited's gross cash position stood at $10.5 billion[16] E-commerce (Shopee) - E-commerce GAAP revenue reached $4.3 billion in Q3 2025[19] - Shopee's GMV is expected to grow by more than 25% for the full year 2025[24] - Ad revenue increased over 70% year-over-year, and the ad take-rate rose by more than 80 basis points year-over-year in Q3 2025[24] Digital Financial Services - Loans principal outstanding reached $7.9 billion, representing a 14.6% quarter-over-quarter increase[10] - Digital Financial Services GAAP revenue was $989.9 million in Q3 2025[19] - Adjusted EBITDA for Digital Financial Services reached $258.3 million[19] Digital Entertainment (Garena) - Digital Entertainment bookings reached $840.7 million, a 27.1% quarter-over-quarter increase[10] - Garena is on track to achieve more than 30% year-over-year growth in bookings for 2025[51] - Adjusted EBITDA for Digital Entertainment was $465.9 million[19]

SKF Group Restructuring - SKF is separating into two standalone companies: SKF Industrial ("Fighting friction") and SKF Automotive ("Moving people further")[8, 10] - The Automotive business spin-off is expected to be operationally ready by mid-2026[17] - SKF Industrial rightsizing activities include a net reduction of approximately 1,200 positions, with about 500 re-hires related to strategic footprint shifts[202] SKF Industrial Financial Targets - SKF Industrial targets organic growth of 4%, which is 1 percentage point above market growth over a business cycle, excluding Automotive contract manufacturing[18, 193] - SKF Industrial aims for an adjusted operating margin of over 17% in the mid-term and over 19% in the long-term[18, 32] - SKF Industrial targets an adjusted ROCE of 20% and a cash conversion rate of 60%[18, 190] - SKF Industrial aims for net zero emissions by 2050 and decarbonized operations by 2030[190] SKF Automotive Financial Objectives - SKF Automotive's indicative long-term objectives include "high single digit" adjusted operating margin and "above market" organic growth over a business cycle[18, 25, 257] - SKF Automotive targets a net leverage of less than 1x (Net Debt (including Pensions) / Adjusted EBITDA)[25, 257] SKF Industrial Growth Strategies - SKF Industrial aims to leverage attractive high-growth industries and geographies, scale recurring service and intelligent solution business, and accelerate Specialized Industrial Solutions[32, 36] - SKF Industrial's Specialized Industrial Solutions account for approximately 25% of revenue[30, 89] - SKF Industrial has seen approximately 10% sales CAGR in Service & Intelligent solutions between 2022 and 2024[73]

Financial Performance - Adjusted net revenue increased slightly by 0.1% from R$5462 million in 3Q24 to R$5468 million in 3Q25[15, 21, 32] - Adjusted EBITDA increased by 14.7% from R$2794 million in 3Q24 to R$3206 million in 3Q25[15, 33, 34] - Adjusted net income increased by 9.5% from R$1173 million in 3Q24 to R$1284 million in 3Q25[15, 110] - Cash flow from operations increased by 21.9% from R$1413 million in 3Q24 to R$1723 million in 3Q25[15] - Cash conversion rate increased from 50.6% in 3Q24 to 53.7% in 3Q25[15] Operational Highlights - Water production volume increased by 4.4% from 775.101 million m³ in 3Q24 to 808.878 million m³ in 3Q25[10] - Water connections increased by 0.6% from 9450 thousand in 3Q24 to 9509 thousand in 3Q25[12] - Sewage connections increased by 1.1% from 8156 thousand in 3Q24 to 8245 thousand in 3Q25[13] Capital Expenditure (CAPEX) - Total CAPEX year-to-date reached R$10430 million[48, 117] - CAPEX for water projects in 3Q25 was R$1155 million, while sewage projects reached R$2823 million[48] - The company has contractual obligations up to 2029, with investments reaching R$38564 million[118, 119] Debt and Ratios - The company issued R$4.9 billion in debt in July, with maturities in 5, 7, and 10 years[62] - 59% of the company's debt matures in 2030 onwards[61, 62] - The company's cash position as of 3Q25 was R$11.6 billion[61, 62]

Detalimogene Voraplasmid & Market Opportunity - The Non-Muscle Invasive Bladder Cancer (NMIBC) market is forecasted to be greater than $20 billion [11] - NMIBC represents 75-80% of bladder cancer diagnoses [14] - Approximately 25,000 US patients per year are diagnosed with High-Risk NMIBC [15] Clinical Trial & Efficacy - The LEGEND study is a global, single-arm, open-label study with a target enrollment of 125 patients with BCG-Unresponsive High-risk NMIBC with CIS [49] - In the post-protocol amendment group (N=62), the Any Time Complete Response (CR) rate was 63% (CI: 51-74) [55, 58] - In the pre-protocol amendment group (N=31), the Any Time Complete Response (CR) rate was 55% (CI: 38-71) [59] Safety & Tolerability - In the Cohort 1 study (n=125), 42.4% of patients experienced at least one Treatment-Related Adverse Event (TRAE) [62] - The most common TRAEs reported in >10% of patients were fatigue (16.8%), dysuria (12.0%), bladder spasm (10.4%), micturition urgency (10.4%), and pollakiuria (10.4%) [62] - Only 1.6% of patients experienced TRAEs leading to dose interruptions, and 0.8% led to dose discontinuations [62] Operational & Financial - Buy+Bill has grown from 5% of revenue in 2008 to 15-20% in 2025 [32] - The company projects its current capital to provide runway into 2027 [78]

Results Presentation 3Q2 5 The ecosystem of solutions created to simplify Brazil's healthcare market Opening Remarks CEO: Leonardo Byrro Priorities Established for 2025 Working Capital Quality x Quantity Operational Excellence Operational Excellence: Expected Improvements 4 ▪ Adjustment of operations with a focus on efficiency and cash generation, reducing the pace of growth. ▪ Discontinuation of businesses with below-expected returns (ROIC) and margin expansion across all business lines. ▪ Reduction of exp ...

ne gogolo. ANNIVERSARY Q3 2025 Investor Presentation NOV 11, 2025 Henry Chiang Chief Executive Officer Gogoro® Q3 2025 Investor Presentation Bruce Aitken Chief Financial Officer 2 DISCLAIMER Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 27E of the Securities Echance Forward-looking statements generally relate to future events or Gogor's tuture imancial or coerating performance. In some ...

PRECIOUS METALS SUMMIT ZURICH NOVEMBER 2025 TSX:JAG 1 OTCQX:JAGGF DISCLAIMERS AND CAUTIONARY STATEMENTS This presentation ("Presentation") does not constitute an offer of any securities for sale or a solicitation of an offer to purchase any securities, nor does it constitute investment advice or an offering memorandum. Readers should review this Presentation in conjunction with all of the public disclosure of Jaguar Mining Inc. ("the Company") available under the Company's profile on www.sedarplus.ca. This ...